Regarding to the association between CRC with obesity and the FTO gene, some studies reported that polymorphisms within the first intronic region of the FTO gene may exert their effects on CRC risk through regulation of the expression level of the FTO gene and subsequent modulation of leptin and adiponectin signaling (23, 24). This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.